Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A High HAQ at Baseline in Early RA Is a Bad Sign

Arthritis & Rheumatology  |  Issue: March 2021  |  January 26, 2021

The association between all-cause mortality and HAQ score at one year remained significant, even after adjustment for confounders. For baseline HAQ score, the unadjusted hazard ratio (HR) was 1.46 (95% confidence interval [95% CI] 1.02–2.09), and the adjusted HR was 1.25 (95% CI 0.81–1.94). For HAQ score at one year, the unadjusted HR was 2.58 (95% CI 1.78–3.72), and the adjusted HR was 1.75 (95% CI 1.10–2.77).

Conclusion

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The findings indicate that a higher HAQ score and DAS at one year are significantly associated with all-cause mortality in a large early RA cohort. Clinicians may find these results helpful to guide discussions with and counseling for patients regarding risk factors, such as smoking cessation, and monitoring treatment response.

Refer to the full study for all source material.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Excerpted and adapted from:

Fatima S, Schier O, Valois MF, et al. Health assessment questionnaire at one year predicts all-cause mortality in patients with early rheumatoid arthritis. Arthritis Rheumatol. 2021 Feb;73(2).

 

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Arthritis & RheumatologyHAQHealth Assessment Questionnaire (HAQ)mortalityResearchRheumatoid Arthritis (RA)

Related Articles

    The Science of MDHAQ/RAPID3 Scores

    December 12, 2011

    Do patient self-reports provide valid data for evidence-based care in rheumatology practice?

    Do Bisphosphonates Reduce Cardiovascular-Related Mortality?

    May 13, 2021

    It is well known that hip fractures are associated with significant morbidity and mortality: Mortality increases 15–25% in the year following a hip fracture.1–5 We know that treating osteo­porosis prevents fractures and improves patient survival. But is there a relationship beyond this? Several studies have found that bisphosphonate therapy is associated with a reduction in…

    Is It Time to Replace the HAQ?

    July 12, 2011

    The PROMIS initiative uses item response theory to improve assessment of patient-reported health and wellbeing

    Letters to the Editor

    June 1, 2007

    Feedback from Our Readers

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences